Barnea Rani, Agmon Inbar Nardi, Shafir Gideon, Peretz Shlomi, Mendel Rom, Naftali Jonathan, Shiyovich Arthur, Kornowski Ran, Auriel Eitan, Hamdan Ashraf
Department of Neurology, Rabin Medical Center - Beilinson Hospital, Petach Tikva, Israel.
Sackler School of Medicine, Tel-Aviv university, Tel-Aviv, Israel.
Eur Stroke J. 2022 Sep;7(3):212-220. doi: 10.1177/23969873221099692. Epub 2022 May 12.
Embolic stroke of undetermined source (ESUS) is a common medical challenge regarding secondary prevention strategy. Cardiac imaging is the cornerstone of embolic stroke workup, in an effort to diagnose high risk cardio-embolic sources. Cardiac computed tomography angiography (CCTA) is an emerging imaging modality with high diagnostic performance for intra-cardiac thrombus detection. The yield of CCTA implementation in addition to standard care in ESUS workup is unknown. Thus, the aim of this study was to assess the utility of CCTA in detecting intra-cardiac thrombi in the routine ESUS workup.
This is a retrospective observational analysis of ESUS cases managed in vascular neurology unit between 2019 and 2021. Within this ESUS registry, consecutive patients undergoing CCTA were included and carefully analyzed.
During the study period 1066 Ischemic stroke (IS) cases were treated and evaluated. 266/1066 (25%) met ESUS criteria and 129/266 (48%) underwent CCTA. Intra-cardiac thrombus was detected by CCTA in 22/129 (17%; 95% CI, 11.5%-23.5%) patients: left ventricular thrombus (LVT) in 13 (10.1%) patients, left atrial appendage (LAA) thrombus in 8 (6.2%) patients, and left atrial (LA) thrombus in 1 (0.8%) patient. Only 5/22 (23%) of these thrombi were suspected, but could not be confirmed, in trans-thoracic echocardiogram (TTE). Among CCTA-undergoing patients, 27/129 (21%; 95% CI, 14%-28%) were found to have an indication (including pulmonary embolism) for commencing anticoagulation (AC) treatment, rather than anti-platelets. In favor of CCTA implementation, 22/266 (8.2%; 95% CI, 4.9%-11.5%) patients within the entire ESUS cohort were diagnosed with intra-cardiac thrombus, otherwise missed.
CCTA improves the detection of intra-cardiac thrombi in addition to standard care in ESUS patients. The implementation of CCTA in routine ESUS workup can change secondary prevention strategy in a considerable proportion of patients.
不明来源栓塞性卒中(ESUS)是二级预防策略中常见的医学挑战。心脏成像检查是评估栓塞性卒中的基石,旨在诊断高风险的心源性栓子来源。心脏计算机断层扫描血管造影(CCTA)是一种新兴的成像方式,对心内血栓检测具有较高的诊断性能。在ESUS评估中,除标准治疗外实施CCTA的诊断率尚不清楚。因此,本研究的目的是评估CCTA在常规ESUS评估中检测心内血栓的效用。
这是一项对2019年至2021年在血管神经科治疗的ESUS病例进行的回顾性观察分析。在这个ESUS登记系统中,纳入了接受CCTA检查的连续患者并进行了仔细分析。
在研究期间,共治疗和评估了1066例缺血性卒中(IS)病例。其中266/1066(25%)符合ESUS标准,129/266(48%)接受了CCTA检查。CCTA在22/129(17%;95%CI,11.5%-23.5%)的患者中检测到心内血栓:13例(10.1%)为左心室血栓(LVT),8例(6.2%)为左心耳(LAA)血栓,1例(0.8%)为左心房(LA)血栓。这些血栓中只有5/22(23%)在经胸超声心动图(TTE)检查中被怀疑但未得到证实。在接受CCTA检查的患者中,27/129(21%;95%CI:14%-28%)被发现有开始抗凝(AC)治疗而非抗血小板治疗的指征(包括肺栓塞)。支持实施CCTA的是,在整个ESUS队列中,22/266(8.2%;95%CI:4.9%-11.5%)的患者被诊断出有心内血栓,否则会被漏诊。
CCTA除了在ESUS患者的标准治疗外,还能提高心内血栓的检测率。在常规ESUS评估中实施CCTA可以在相当一部分患者中改变二级预防策略。